Clinical Trials
13
Active:0
Completed:12
Trial Phases
2 Phases
Phase 3:3
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 3
3 (75.0%)Phase 4
1 (25.0%)Lead Extraction With Manual Traction
Completed
- Conditions
- Pacemaker Lead DysfunctionManual Traction
- First Posted Date
- 2025-06-17
- Last Posted Date
- 2025-06-17
- Lead Sponsor
- Bursa Postgraduate Hospital
- Target Recruit Count
- 130
- Registration Number
- NCT07023900
Evaluation Of The Effect Of SGLT-2 Inhibitors On Atrial Fibrillation Recurrence In Diabetic Patients
Completed
- Conditions
- Diabetes MellitusAtrial Fibrillation (AF)
- First Posted Date
- 2025-04-30
- Last Posted Date
- 2025-06-03
- Lead Sponsor
- Bursa Postgraduate Hospital
- Target Recruit Count
- 120
- Registration Number
- NCT06951737
- Locations
- 🇹🇷
Bursa Yüksek İhtisas Hastanesi, Bursa, Turkey
Nitrate - Clopidogrel - Acute Coronary Syndrome
Completed
- Conditions
- Acute Coronary Syndromes
- First Posted Date
- 2025-03-17
- Last Posted Date
- 2025-03-17
- Lead Sponsor
- Bursa Postgraduate Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT06878638
- Locations
- 🇹🇷
Bursa Yüksek İhtisas Hastanesi, Bursa, Turkey
Rivaroxaban - Percutaneous Coronary Intervention
- First Posted Date
- 2022-09-15
- Last Posted Date
- 2022-09-15
- Lead Sponsor
- Bursa Postgraduate Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT05541757
- Locations
- 🇹🇷
Bursa Yüksek İhtisas Eğitim ve Araştırma Hastanesi, Bursa, Turkey
Safety And Efficacy Results of Percutaneous Renal Stent Implantation in Ectatic and Aneurysmatic Coronary Arteries
Phase 4
Completed
- Conditions
- Coronary Artery Ectasia
- Interventions
- Drug: Renal stent
- First Posted Date
- 2022-06-08
- Last Posted Date
- 2022-06-08
- Lead Sponsor
- Bursa Postgraduate Hospital
- Target Recruit Count
- 63
- Registration Number
- NCT05410678
- Prev
- 1
- 2
- 3
- Next
News
No news found